Vinci Pharmaceuticals, Inc.
EPIPLANT, a needle-free drug delivery platform for intravitreal administration of therapeutics to treat retinal diseases
Follows are private to you and power your alerts
Updated · vincipharmaceuticals.com
- Sector
- Medtech
- Headquarters
- Avon by the Sea, NJ
- Founded
- 2019
- Latest Form D
- $20.2M, Jan 2026
- Total capital
- $21.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $21.2M
- 2 Form D · last Jan 2026
- 9 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$20.2M
- Private capital raisedForm D · SEC · 1st filing$1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Neil Austrian Jr.DirectorNamed in SEC Form D filings
- Philip GioiaExecutive Officer, DirectorNamed in SEC Form D filings
- Richard LindstromDirectorNamed in SEC Form D filings
- Sarah HassanDirectorNamed in SEC Form D filings
- Sigurd KirkDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingOcular Device And MethodsUSPTOApplication 18686696
- PendingOcular Device And MethodsUSPTOApplication PCTUS2022075538
- PendingOcular Device And MethodsUSPTOApplication 63260621
Related companies, and why
- Momentum Women LLCSimilar federal contract value in Medtech · null in contracts
- SAVICELL CorpSimilar federal contract value in Medtech · null in contracts
- Nasseo, Inc.Similar federal contract value in Medtech · null in contracts
- ACTIV Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- AlgoSurgSimilar federal contract value in Medtech · null in contracts
- BrainStem BiometricsSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .